KDSK.F Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
DSM-Firmenich AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €43.10 |
52 Week High | €133.35 |
52 Week Low | €12.50 |
Beta | 0 |
1 Month Change | -64.08% |
3 Month Change | 38.99% |
1 Year Change | -64.55% |
3 Year Change | -75.23% |
5 Year Change | -60.90% |
Change since IPO | -6.05% |
Recent News & Updates
Recent updates
Shareholder Returns
KDSK.F | US Chemicals | US Market | |
---|---|---|---|
7D | -4.2% | 0.01% | 1.0% |
1Y | -64.5% | 18.0% | 31.2% |
Return vs Industry: KDSK.F underperformed the US Chemicals industry which returned 14.4% over the past year.
Return vs Market: KDSK.F underperformed the US Market which returned 27.7% over the past year.
Price Volatility
KDSK.F volatility | |
---|---|
KDSK.F Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 5.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KDSK.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KDSK.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1902 | 28,685 | Dimitri de Vreeze | https://www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
KDSK.F fundamental statistics | |
---|---|
Market cap | US$30.62b |
Earnings (TTM) | -US$714.21m |
Revenue (TTM) | US$11.53b |
2.6x
P/S Ratio-42.0x
P/E RatioIs KDSK.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KDSK.F income statement (TTM) | |
---|---|
Revenue | €10.63b |
Cost of Revenue | €8.02b |
Gross Profit | €2.61b |
Other Expenses | €3.27b |
Earnings | -€658.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
Earnings per share (EPS) | -2.48 |
Gross Margin | 24.57% |
Net Profit Margin | -6.19% |
Debt/Equity Ratio | 19.2% |
How did KDSK.F perform over the long term?
See historical performance and comparison